Valylvaline

CAS No. 3918-94-3

Valylvaline( —— )

Catalog No. M33679 CAS No. 3918-94-3

Valylvaline (Val-val) is a dipeptide compound that can be used for protein synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 28 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Valylvaline
  • Note
    Research use only, not for human use.
  • Brief Description
    Valylvaline (Val-val) is a dipeptide compound that can be used for protein synthesis.
  • Description
    H-VAL-VAL-OH is a dipeptide of the amino acid valine, an essential amino acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3918-94-3
  • Formula Weight
    216.28
  • Molecular Formula
    C10H20N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 9.52 mg/mL (44.02 mM; ultrasonic and adjust pH to 4 with 1M HCl; )H2O : < 0.1 mg/mL (insoluble)
  • SMILES
    [C@H](NC([C@H](C(C)C)N)=O)(C(C)C)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pierfrancesco Bravo, et al. Solution and solid-phase synthesis of trifluoromethyl peptides and mimetics. Journal of Fluorine Chemistry Volume 112, Issue 1, 28 November 2001, Pages 153-162.
molnova catalog
related products
  • Dansylglycine

    Dansylglycine is a fluorescent probe for specific determination of halogenating activity of myeloperoxidase and eosinophil peroxidase.

  • Proteinase

    Proteinases are enzymes that catalyse the breakdown of proteins. Proteinases are involved in many biological functions, including the digestion of ingested proteins, the breakdown of old proteins, and cell signalling.

  • Astragenol

    Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.